Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in Parkinson's disease patients: a double-blind single-dose study.

Source:http://linkedlifedata.com/resource/pubmed/id/9099469

Download in:

View as

General Info

PMID
9099469